SG11201808685SA - Composition for improving brain function for neonates - Google Patents

Composition for improving brain function for neonates

Info

Publication number
SG11201808685SA
SG11201808685SA SG11201808685SA SG11201808685SA SG11201808685SA SG 11201808685S A SG11201808685S A SG 11201808685SA SG 11201808685S A SG11201808685S A SG 11201808685SA SG 11201808685S A SG11201808685S A SG 11201808685SA SG 11201808685S A SG11201808685S A SG 11201808685SA
Authority
SG
Singapore
Prior art keywords
neonates
composition
brain function
improving brain
improving
Prior art date
Application number
SG11201808685SA
Other languages
English (en)
Inventor
Satoshi Kusuda
Satsuki TOTSU
Masaki Terahara
Original Assignee
Meiji Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=60042139&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201808685S(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Meiji Co Ltd filed Critical Meiji Co Ltd
Publication of SG11201808685SA publication Critical patent/SG11201808685SA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/517—Bifidum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Pediatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11201808685SA 2016-04-13 2017-04-12 Composition for improving brain function for neonates SG11201808685SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016080676 2016-04-13
PCT/JP2017/014915 WO2017179602A1 (ja) 2016-04-13 2017-04-12 新生児向けの脳機能改善用組成物

Publications (1)

Publication Number Publication Date
SG11201808685SA true SG11201808685SA (en) 2018-11-29

Family

ID=60042139

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201808685SA SG11201808685SA (en) 2016-04-13 2017-04-12 Composition for improving brain function for neonates

Country Status (9)

Country Link
US (1) US10925906B2 (ja)
EP (1) EP3443969B1 (ja)
JP (1) JP7088829B2 (ja)
CN (1) CN109069555B (ja)
AU (1) AU2017251028A1 (ja)
CA (1) CA3020578A1 (ja)
SG (1) SG11201808685SA (ja)
TW (1) TWI744311B (ja)
WO (1) WO2017179602A1 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX338174B (es) 2010-12-31 2016-04-06 Abbott Lab Metodos para reducir la incidencia de la tension oxidativa al usar los oligosacaridos de leche humana, la vitamina c y los agentes antiinflamatorios.
US9539269B2 (en) 2010-12-31 2017-01-10 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
CA2842672A1 (en) 2011-07-22 2013-01-31 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
SG2014013478A (en) 2011-08-29 2014-05-29 Abbott Lab Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
JP7088829B2 (ja) 2016-04-13 2022-06-21 株式会社明治 新生児向けの脳機能改善用組成物
CN114206136A (zh) 2019-08-08 2022-03-18 森永乳业株式会社 用于改善学龄期的记忆能力的婴幼儿用组合物
JP2023511678A (ja) * 2020-01-24 2023-03-22 森永乳業株式会社 神経突起伸長改善用組成物
WO2022131192A1 (ja) 2020-12-16 2022-06-23 株式会社明治 脳組織の炎症改善用組成物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2826808B2 (ja) * 1995-07-14 1998-11-18 カルピス株式会社 脳機能改善、学習能力増強および記憶力増強作用を有する機能性食品
US6309461B1 (en) 1999-06-07 2001-10-30 Sandia Corporation Crystal growth and annealing method and apparatus
IT1311495B1 (it) 1999-06-09 2002-03-13 Mendes S U R L Composizione comprendente sfingomielinasi alcalina, utilizzabile qualeprodotto dietetico, integratore alimentare o medicamento.
US7943124B2 (en) * 2005-02-02 2011-05-17 Meiji Dairies Corporation Composition for immunostimulation
JP5273695B2 (ja) 2005-03-03 2013-08-28 株式会社明治 ビフィズス菌を有効成分とするアレルギー予防および／または治療剤
CN101636167B (zh) * 2006-12-28 2012-10-03 株式会社明治 含有乳来源的磷脂的婴幼儿脑发育促进剂以及含有该促进剂的食品组合物
EP2110028A1 (en) 2008-04-15 2009-10-21 Nestec S.A. Bifidobacterium longum and hippocampal BDNF expression
JP5923238B2 (ja) * 2010-07-07 2016-05-24 アサヒグループホールディングス株式会社 迷走神経活性化剤
DK2593466T3 (en) 2010-07-12 2018-07-16 Univ California Oligosaccharides from cow's milk
US9567361B2 (en) 2011-05-13 2017-02-14 Glycosyn LLC Use of purified 2′-fucosyllactose, 3-fucosyllactose and lactodifucotetraose as prebiotics
US20140271562A1 (en) * 2011-10-18 2014-09-18 Nestec S.A. Composition for use in brain growth and/or cognitive and/or psychomotor development
EP2609814A1 (en) * 2011-12-30 2013-07-03 Nestec S.A. Lactobacillus reuteri DSM 17938 for the development of cognitive function
US9974816B2 (en) * 2012-11-02 2018-05-22 N.V. Nutricia Synbiotics combination for brain improvement
WO2014148887A1 (en) 2013-03-22 2014-09-25 N.V. Nutricia Fermented nutrition with non-digestible oligosaccharides with increased iron bioavailability
CN104000188A (zh) 2013-12-09 2014-08-27 胡安然 一种儿童益智补脑者食用的特殊膳食
JP5745197B1 (ja) 2015-01-27 2015-07-08 ゼロサムアース株式会社 放射性セシウムの除去方法
JP7088829B2 (ja) 2016-04-13 2022-06-21 株式会社明治 新生児向けの脳機能改善用組成物

Also Published As

Publication number Publication date
EP3443969B1 (en) 2021-12-22
JP7088829B2 (ja) 2022-06-21
TW201803576A (zh) 2018-02-01
CA3020578A1 (en) 2017-10-19
AU2017251028A1 (en) 2018-11-29
JPWO2017179602A1 (ja) 2019-02-21
EP3443969A1 (en) 2019-02-20
CN109069555A (zh) 2018-12-21
US10925906B2 (en) 2021-02-23
US20190134114A1 (en) 2019-05-09
TWI744311B (zh) 2021-11-01
WO2017179602A1 (ja) 2017-10-19
EP3443969A4 (en) 2019-11-20
CN109069555B (zh) 2022-07-26

Similar Documents

Publication Publication Date Title
DK3478217T3 (en) Historisk scanningsreference for intraorale scanninger
EP3466435C0 (en) BRAIN FUNCTION IMPROVING AGENT
GB201614134D0 (en) Novel compounds
GB201616627D0 (en) Novel compounds
GB201616511D0 (en) Novel compounds
GB201604647D0 (en) Novel compounds
GB201604638D0 (en) Novel compounds
GB201610147D0 (en) Novel compounds
GB201602854D0 (en) Novel compounds
GB201603779D0 (en) Novel compounds
HK1244744B (zh) 乘坐裝置
SG11201808685SA (en) Composition for improving brain function for neonates
GB201613163D0 (en) Novel compounds
IL255692B (en) Composition for treating brain lesions
PL3273947T3 (pl) Kompozycja dla zdrowia oczu
RS61490B1 (sr) Kompozicije za pojačanje moždane aktivnosti
GB201618346D0 (en) Novel compounds
HK1247088A1 (zh) 腦機能改善組合物
GB201619514D0 (en) Novel compounds
GB201601301D0 (en) Novel compounds
GB201615191D0 (en) Novel compounds
GB201600899D0 (en) Intermediate compounds
PT3445377T (pt) Composições para a pele
GB201616907D0 (en) Novel Compounds
GB201616348D0 (en) Novel compounds